Team:Warwick/Parts/IRES
From 2014.igem.org
(Difference between revisions)
(2 intermediate revisions not shown) | |||
Line 43: | Line 43: | ||
<!--CONTENT START--> | <!--CONTENT START--> | ||
+ | |||
+ | <a href="https://2014.igem.org/Main_Page"> <img class = "headerImage" style = "width: 12%;" | ||
+ | src="https://static.igem.org/mediawiki/2014/2/22/Logo2014v2.png"> </a> | ||
<a href="/Team:Warwick"> <img class = "headerImage" style = "width: 30%;" src="https://static.igem.org/mediawiki/2014/f/ff/RepliconLogoON.png"> </a> | <a href="/Team:Warwick"> <img class = "headerImage" style = "width: 30%;" src="https://static.igem.org/mediawiki/2014/f/ff/RepliconLogoON.png"> </a> | ||
- | + | <a href="/Team:Warwick"> <img class = "headerImage" style = "width: 12%;" | |
+ | src="https://static.igem.org/mediawiki/2014/f/f6/Warwick_logo.png"> </a> | ||
<div id = "mainMenuBar"> | <div id = "mainMenuBar"> | ||
Line 58: | Line 62: | ||
<li> <a href = "/Team:Warwick/Interlab"> INTERLAB </a> </li> | <li> <a href = "/Team:Warwick/Interlab"> INTERLAB </a> </li> | ||
<li> <a href = "/Team:Warwick/Attributions"> ATTRIBUTIONS </a> </li> | <li> <a href = "/Team:Warwick/Attributions"> ATTRIBUTIONS </a> </li> | ||
- | + | ||
</div> | </div> | ||
Line 70: | Line 74: | ||
<li> <a href = "/Team:Warwick/Parts/P2a"> P2A </a> </li> | <li> <a href = "/Team:Warwick/Parts/P2a"> P2A </a> </li> | ||
<li> <a href = "/Team:Warwick/Parts/MS2"> MS2 </a> </li> | <li> <a href = "/Team:Warwick/Parts/MS2"> MS2 </a> </li> | ||
- | <li> <a href = "/Team:Warwick/Parts/3promoter"> PROMOTERS </a> </li> | + | <li> <a href = "/Team:Warwick/Parts/3promoter"> RNA PROMOTERS </a> </li> |
<li> <a href = "/Team:Warwick/Parts/Testing"> TESTING MODULES </a> </li> | <li> <a href = "/Team:Warwick/Parts/Testing"> TESTING MODULES </a> </li> | ||
<li> <a href = "/Team:Warwick/Parts/bb"> EXISTING BIOBRICK </a> </li> | <li> <a href = "/Team:Warwick/Parts/bb"> EXISTING BIOBRICK </a> </li> |
Latest revision as of 02:14, 18 October 2014
IRES
This acts as an initiation for eukaryotic ribosomes and begins translation of the following protein sequence. We compared two different IRESs: the classical EMCV IRES used in many papers,which has been shown to be compatible with replicons and the NKRF IRES derived from the 3’UTR of the mammalian NF-kappaB repressing factor, which we also chose to test because during investigation regarding the efficacy and strength of the EMCV IRES, the NKRF derived IRES was shown to be 30-fold more efficient however had never been previously used in Huh7.